States and health care providers may use regulatory flexibilities available during the COVID-19 public health emergency to help respond to non-COVID-19 illnesses straining hospital and health care systems, such as flu and Respiratory Syncytial Virus, Health and Human Services Secretary Xavier Becerra told governors Dec. 2.

“They remain available to you and health care providers as you all make care available in response to flu, RSV, COVID-19, and other illnesses,” Becerra wrote

Among other actions, he said the Administration for Strategic Preparedness and Response “stands ready to evaluate any formal request for federal medical assistance – including requests for medical personnel – working in close coordination with the requesting state/jurisdiction to determine the needs and availability of matching resources.”

Headline
There are now 17,180 confirmed cases of cyclosporiasis in the U.S., the Centers for Disease Control and Prevention reported Aug. 25. At least 11,844 additional…
Headline
The Food and Drug Administration has approved a blood test for detecting Alzheimer’s by Roche and Eli Lilly, according to an announcement Aug. 24 by Roche. The…
Headline
There have been 15,716 confirmed cases of cyclosporiasis across 47 states, Washington, D.C., and Puerto Rico since May 1, the Centers for Disease Control and…
Blog
By Rani E. Snyder, President, The John A. Hartford Foundation and Dr. Chris DeRienzo, AHA Chief Physician Executive/President of AHA’s HRET As the U.S.…
Headline
The Department of Health and Human Services Aug. 14 announced that three health systems have signed the agency’s voluntary pledge related to hospital efforts…
Headline
The Centers for Disease Control and Prevention Aug. 11 released a health advisory on the risk of severe arboviral disease among patients receiving B-cell-…